Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia

NCT02547662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Plasma Cell Leukemia
Plasma Cell Myeloma
Plasmacytoma

Interventions

DRUG: Dexamethasone
DRUG: Ixazomib Citrate
OTHER: Laboratory Biomarker Analysis
DRUG: Pomalidomide

Sponsor

Mayo Clinic